445680 — Curiox BioSystems Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Curiox BioSystems Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	19,819	8,722	17,909	28,188	17,785
Net Total Accounts Receivable
Net Total Receivables	1,330	1,921	1,850	768	2,170
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23,060	13,949	21,601	32,267	40,155
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	543	998	2,391	2,095	1,762
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	55,793	48,627	57,798	70,561	78,027
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	48,395	2,835	2,717	19,918	23,377
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	50,211	4,775	4,919	21,928	25,222
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	5,582	43,853	52,879	48,632	52,805
Total Liabilities & Shareholders' Equity	55,793	48,627	57,798	70,561	78,027
Total Common Shares Outstanding